| __timestamp | Ligand Pharmaceuticals Incorporated | Novartis AG |
|---|---|---|
| Wednesday, January 1, 2014 | 55402000 | 36289000000 |
| Thursday, January 1, 2015 | 66107000 | 32983000000 |
| Friday, January 1, 2016 | 103402000 | 31916000000 |
| Sunday, January 1, 2017 | 135736000 | 32960000000 |
| Monday, January 1, 2018 | 245116000 | 34759000000 |
| Tuesday, January 1, 2019 | 108935000 | 34252000000 |
| Wednesday, January 1, 2020 | 156000000 | 34777000000 |
| Friday, January 1, 2021 | 214957000 | 37010000000 |
| Saturday, January 1, 2022 | 143418000 | 36342000000 |
| Sunday, January 1, 2023 | 96265000 | 34188000000 |
| Monday, January 1, 2024 | 38895000000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of pharmaceuticals, the financial performance of industry leaders offers a window into their strategic prowess. From 2014 to 2023, Novartis AG and Ligand Pharmaceuticals Incorporated have showcased contrasting trajectories in gross profit. Novartis, a Swiss multinational, consistently reported robust figures, peaking in 2021 with a gross profit of approximately $36.3 billion. This represents a steady growth of around 13% from its lowest point in 2016. Meanwhile, Ligand Pharmaceuticals, a smaller yet innovative player, experienced a more volatile journey. Its gross profit surged by over 340% from 2014 to 2018, reaching a high of $245 million, before experiencing fluctuations in subsequent years. This comparison highlights the resilience and adaptability of these companies in a competitive market, offering valuable insights into their financial strategies and market positioning.
Eli Lilly and Company vs Novartis AG: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Novartis AG vs Vertex Pharmaceuticals Incorporated
Gross Profit Trends Compared: Novartis AG vs Gilead Sciences, Inc.
Key Insights on Gross Profit: Novartis AG vs Dr. Reddy's Laboratories Limited
Novartis AG and Amneal Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Novartis AG or Arrowhead Pharmaceuticals, Inc.
Cost of Revenue Trends: Novartis AG vs Ligand Pharmaceuticals Incorporated
Gross Profit Comparison: Bristol-Myers Squibb Company and Ligand Pharmaceuticals Incorporated Trends
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated
Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs Ligand Pharmaceuticals Incorporated
MorphoSys AG and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis